DoxorubicinCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsEtoposideLomustineVinca AlkaloidsAntineoplastic Agents, PhytogenicBleomycinVinblastineMethotrexateP-GlycoproteinDrug ResistanceAntibodies, Monoclonal, Murine-DerivedLeukemia P388Lymphoma, Non-HodgkinAsparaginaseAntineoplastic AgentsCombined Modality TherapyDaunorubicinDrug Resistance, MultiplePrednisoloneLymphoma, Large B-Cell, DiffuseRhabdomyosarcomaDrug Administration ScheduleRemission InductionCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaHodgkin DiseaseDactinomycinMelphalanIfosfamideOligodendrogliomaTreatment OutcomeDexamethasoneVerapamilDisease-Free SurvivalCarcinoma, Small CellDacarbazineDrug Resistance, NeoplasmCatharanthusSurvival AnalysisVindesineLeukemia, LymphoidCisplatinTeniposideSurvival RateColchicineSemustinePodophyllotoxinChlorambucilMitoxantroneLeukemia L1210Sarcoma, EwingMultiple MyelomaWilms TumorKB CellsTumor Cells, CulturedAntibiotics, AntineoplasticMultidrug Resistance-Associated ProteinsNimustineCarmustineLymphoma, FollicularDrug Screening Assays, AntitumorDose-Response Relationship, DrugNeoplasm StagingDrug SynergismBrain NeoplasmsPrognosisPeripheral Nervous System DiseasesLymphoma, B-CellLymphomaLiposomesCell SurvivalMedulloblastomaAntimitotic AgentsPaclitaxelTime Factors6-MercaptopurineMesnaAstrocytomaLung NeoplasmsMicrotubulesNeuroblastomaTubulinLeukotriene C4MitolactolCerebellar NeoplasmsLeukemia, ExperimentalDrug CarriersTopotecanPeptichemioCentral Nervous System NeoplasmsFollow-Up StudiesNeoplasm Recurrence, LocalCarboplatinRecurrenceActuarial AnalysisAbdominal NeoplasmsSupratentorial NeoplasmsHematologic Diseases